Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

INTRODUCTION: Apolipoprotein complement is a critical determinant of lipoprotein function and metabolism. The relation between exogenous insulin and apolipoproteins (apos) in newly diagnosed type 1 diabetes mellitus (T1DM) has not yet been studied extensively. The aim of this study was to prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieluch, Aleksandra, Uruska, Aleksandra, Nowicki, Marcin, Wysocka, Ewa, Niedźwiecki, Paweł, Grzelka-Woźniak, Agata, Flotyńska, Justyna, Zozulińska-Ziółkiewicz, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103612/
https://www.ncbi.nlm.nih.gov/pubmed/35591821
http://dx.doi.org/10.5114/aoms.2020.100255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103612/
https://www.ncbi.nlm.nih.gov/pubmed/35591821
http://dx.doi.org/10.5114/aoms.2020.100255

Ejemplares similares